LucasMcCarthyMDMS

Neuroimmunology/Multiple Sclerosis

Neurologist

Dr. McCarthy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1100 9th Ave
Mailstop: X7-NEU
Seattle, WA 98101
Phone+1 206-341-0420

Fax+1 206-625-7240

University of WashingtonFellowship, Neuroimmunology & Multiple Sclerosis, 2013 - 2015
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2010 - 2013
California Pacific Medical CenterInternship, Internal Medicine, 2009 - 2010
Albert Einstein College of MedicineClass of 2009

PubMed

5 citations
Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord
Journal of Immunology. 2022-04-01
20 citations
Fewer LAG-3T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.
Britta E Jones, Megan D Maerz, Henry T Bahnson, Ashwin Somasundaram, Lucas H McCarthy
Journal of Immunology. 2022-02-01
1 citations
In ASCVD, 81 mg and 325 mg of aspirin did not differ for CV or bleeding events.
Lucas McCarthy
Annals of Internal Medicine. 2021-10-01

Abstracts/Posters

Functional Polymorphisms of Catechol-O-Methyl Transferase (COMT) and Dopamine Beta-Hydroxylase (DBH) and Chronic Pain in the Elderly
Richard B Lipton, Lucas McCarthy, Mindy Katz, Laurie Ozelius, Neurology, 3/2/2010

Virginia Mason Medical Center - Provider Profilehttps://www.vmfh.org/find-a-doctor/neurology/lucas-mccarthy-1053624502
Virginia Mason MS Centerhttps://www.vmfh.org/ms